FDA Adverse Event Malfunction Summary report: N

BD PHOENIX¿ NMIC-306

MDR report key: 21325569 · Received February 6, 2025

Report

Report Number
1119779-2025-00040
Event Type
Malfunction
Date Received
February 6, 2025
Date of Event
December 18, 2024
Report Date
April 3, 2025
Manufacturer
BECTON DICKINSON & CO. (SPARKS)
Product Code
LON
UDI-DI
30382904492923
PMA / PMN Number
SEE H11
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THERE WERE MULTIPLE 510K NUMBERS REPORTED TO BE INVOLVED. THE INFORMATION FOR THE ADDITIONAL 510K IS AS FOLLOWS: G4. PMA / 510(K)#: K020322, K022129, K023444, K023634, K023858, K024153, K031530, K031699, K031912, K032299, K032567, K032655, K033362, K033560, K041384, K042932, K052269, K060214, K060217, K060257, K060444, K060447, K061327, K061355, K062207, K062944, K063301, K063486, K063573, K063811, K063824, K071623, K132674, K132909, K151320, K181665, K173252, K190905, K163637, K173523, K033458, AND K123266. H3. A DEVICE EVALUATION IS ANTICIPATED BUT HAS NOT YET BEGUN. UPON COMPLETION OF THE INVESTIGATION, A SUPPLEMENTAL REPORT WILL BE FILED.

Additional Manufacturer Narrative · 0

INVESTIGATION SUMMARY - THIS COMPLAINT IS FOR HIGH MIC MEROPENEM (MEM) WITH PSEUDOMONAS AERUGINOSA, KLEBSIELLA AEROGENES, ESCHERICHIA COLI, PROTEUS MIRABILIS, KLEBSIELLA PNEUMONIAE AND SERRATIA MARCESCENS WHEN USING PHOENIX PANEL NMIC-306 (CATALOG NUMBER 449292) BATCH NUMBER 4289942. THE CUSTOMER DID NOT RETURN PANELS BUT RETURNED ISOLATES, PHOENIX GENERATED LAB REPORTS AND BINARY FILES FOR THE INVESTIGATION. THE PHOENIX GENERATED LAB REPORTS SHOW HIGH MIC MEM WITH PSEUDOMONAS AERUGINOSA, KLEBSIELLA AEROGENES, ESCHERICHIA COLI, PROTEUS MIRABILIS, KLEBSIELLA PNEUMONIAE AND SERRATIA MARCESCENS WHEN USING THE COMPLAINT BATCH. TO INVESTIGATE, RETENTION PANELS OF THE COMPLAINT BATCH WERE TESTED USING CUSTOMER RETURNED ISOLATES P. AERUGINOSA N804023712, K. AEROGENES N806007690, E. COLI N80815124, P. AERUGINOSA N80915110, E. COLI N81401833, P. MIRABILIS N81600821, E. COLI N818021141, K. PNEUMONIAE N80502111, S. MARCESCENS N807007492, K. PNEUMONIAE N81316418 AND P. AERUGINOSA N8191012315 ON A PHOENIX M50 MACHINE AND EVALUATED FOR MEM MIC RESULTS. ALSO, CONTROL PANELS FROM THE SAME MATERIAL BUT DIFFERENT BATCH WERE TESTED USING CUSTOMER RETURNED ISOLATES P. AERUGINOSA N804023712, K. AEROGENES N806007690, E. COLI N80815124, P. AERUGINOSA N80915110, E. COLI N81401833, P. MIRABILIS N81600821, E. COLI N818021141, K. PNEUMONIAE N80502111, S. MARCESCENS N807007492, K. PNEUMONIAE N81316418 AND P. AERUGINOSA N8191012315 ON A PHOENIX M50 MACHINE AND EVALUATED FOR MEM MIC RESULTS. ALL PANELS TESTED RETURNED THE EXPECTED SENSITIVE MICS FOR MEM, THIS COMPLAINT IS NOT CONFIRMED. A REVIEW OF THE BINARY FILES WAS DETERMINED NOT TO BE REQUIRED BASED ON THE RESULTS OF THE INVESTIGATION. THE BATCH HISTORY RECORD WAS SATISFACTORY AND NO QUALITY NOTIFICATIONS WERE GENERATED DURING MANUFACTURING AND INSPECTION. COMPLAINT TRENDING WAS PERFORMED AND NO TRENDS WERE IDENTIFIED ASSOCIATED WITH THIS DEFECT. BD WILL CONTINUE TO MONITOR FOR TRENDS AND TAKE ACTION AS NECESSARY. PLEASE CONTINUE TO COMMUNICATE ANY ADDITIONAL CONCERNS.

Description of Event or Problem · 0

IT WAS REPORTED WHILE USING THE BD PHOENIX¿ NMIC-306 AN UNSPECIFIED NUMBER OF PATIENT ISOLATES HAD HIGH MICS FOR THE DRUG MEROPENEM. CONFIRMATORY TESTING WAS PERFORMED USING E-TEST STRIP. NO HEALTH IMPACT OR CONSEQUENCE REPORTED.

Description of Event or Problem · 0

IT WAS REPORTED WHILE USING THE BD PHOENIX¿ NMIC-306 AN UNSPECIFIED NUMBER OF PATIENT ISOLATES HAD HIGH MICS FOR THE DRUG MEROPENEM. CONFIRMATORY TESTING WAS PERFORMED USING E-TEST STRIP. NO HEALTH IMPACT OR CONSEQUENCE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
631416 BD PHOENIX¿ NMIC-306 SYSTEM, TEST, AUTOMATED ANTIMICROBIAL SUSCEPTIBILITY, SHORT INCUBATION LON BECTON DICKINSON & CO. (SPARKS) 4289942 30382904492923

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown